In Use Product Safety Assessment: Teriparatide injection

David Erskine, Director, London Medicines Information Services, Specialist Pharmacy ServicePublished

The availability of four teriparatide preparations (originator, two biosimilars and a generic version) in the UK market creates a potential for confusion in the prescribing, dispensing, and administration of these products. This review summarises safety considerations associated with the use of these products.

Attachments